Company / EPS (Diluted)
Glaukos Corp. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.78
FY2025
5-year range
-$2.78 / $0.37
FY2021-FY2025
Trend
-33.0%
vs FY2024
Sector context
#138 of 159
Health Care
What the data says
Glaukos Corp.'s eps (diluted) of $-2.78 is lower than 87% of companies in the Health Care sector (FY2025). EPS (Diluted) has fluctuated over the past 10 years, ranging from $-5.29 in FY2016 to $0.37 in FY2021.
Based on SEC 10-K filings.
-2.78 in FY2025.
Declined from $-1.07 to $-2.78 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 159This company -$2.78 Sector average $1.64
▼
-269.7% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 33.0% year-over-year.
- Ranks #138 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2021.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.78 | -33.0% |
| FY2024 | -$2.09 | -95.3% |
| FY2023 | -$1.07 | +60.4% |
| FY2022 | -$2.70 | -829.7% |
| FY2021 | $0.37 | +200.0% |
| FY2020 | -$0.37 | - |
| FY2019 | $0.00 | -100.0% |
| FY2018 | $0.12 | +105.6% |
| FY2017 | -$2.13 | +59.7% |
| FY2016 | -$5.29 | -1222.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026